News & Events
Join Pelago Bioscience and Washington University for a Live Seminar on Drug-Target Engagement
Discover CETSA® in Action Pelago Bioscience, in collaboration with the Center for Drug Discovery at Washington University in St. Louis, invites you to a seminar exploring real-world applications of C...
Heading to 22nd BioPharma Drug Discovery Nexus Conference
April 29–30, 2025 | Brussels, Belgium Pelago Bioscience is joining the 22nd BioPharma Drug Discovery Nexus Conference, a key meeting point for R&D leaders working to accelerate early-stage drug d...
Pelago Bioscience showcases at AACR 2025
April 25–30, 2025 | Chicago, IL | Booth #1656 Pelago Bioscience is exhibiting at the AACR Annual Meeting 2025, where oncology and drug discovery professionals gather to share the latest scientif...
Pelago Bioscience presents at LRIG Philadelphia Annual Vendor Exhibition
Pelago Bioscience is proud to participate in the LRIG Philadelphia Annual Vendor Exhibition. This event brings together scientists, researchers, and technology leaders to explore the latest innovation...
Find us at at Drug Discovery Chemistry 2025
Pelago Bioscience will attend Drug Discovery Chemistry 2025 in San Diego from April 14 to 17. This event is a leading forum for researchers and industry professionals focused on advancements in medici...
We’re attending BPS New Therapeutic Modalities 2025
Pelago Bioscience is attending New Therapeutic Modalities: Transforming Receptor Pharmacology, hosted by the British Pharmacological Society, on April 2–3 in Cambridge, UK. This event will bring toget...
Meet Pelago Bioscience at ELRIG Research & Innovation 2025
Pelago Bioscience is excited to participate in ELRIG Research & Innovation 2025, which will be held on March 10–11 at the Royal Society of Medicine in London. This event brings together experts fr...
Join us at US Drug Discovery Innovation Programme 2025
We are attending the US Drug Discovery Innovation Programme 2025 in San Diego, March 3–4, where industry leaders will gather to explore the latest advancements in drug discovery. Meet our team a...
Webinar: Applying CETSA® to Translational Studies – A Sitryx Story
Bridging the Gap Between In Vitro and In Vivo with CETSA 4 March 2025 17:00 CET | 16:00 GMT | 11:00 EST | 08:00 PST Missed the Webinar? We’ve Got You Covered! Translating early drug discovery in...
Let’s Connect at EFMC-ISCB 2025, Basel
We are attending EFMC-ISCB 2025 in Basel, January 29 to 31, and we’re excited to meet you there. Stop by Booth #8 to connect with our team, including Laurence Arnold (Head of R&D), Mitko Dimitrov ...
The Koehler Lab at MIT acknowledges Pelago Bioscience’s patent and use of CETSA® process
Pelago Bioscience celebrates that the Koehler Lab at the Massachusetts Institution of Technology found CETSA® to be a valuable method for quantifying drug Target Engagement in the lab’s experiments de...
We’re attending SLAS 25
Meet us on January 25-29, San Diego Convention Center San Diego, CA (USA). Don’t miss our poster presentation: Title: Enhancing degrader research with CETSA.Date: January 28thTime: 2:00–3:00 pm Meet o...
University of Southampton acknowledges Pelago Bioscience’s patent and use of CETSA® process
Pelago Bioscience is excited about University of Southampton researchers, led by Professor Tavassoli, having found our patented CETSA® technology useful in their research into identifying hypoxia-indu...
Join our Webinar
How CETSA® has been applied in Lead Generation delivering novel modulators of PLCγ2 4 December 2024 17:00 CET | 16:00 GMT | 11:00 EST | 08:00 PST Featured Speaker Fiona Jeganathan Head of Pharmac...
Meet us at BIO-Europe 2024
November 4-6, Stockholmsmässan | Stockholm – Sweden. Our CEO, Michael Dabrowski along with Regional Sales Manager Marianne Alksnis and Head of Sales Magnus Lejelöv, will be attending the Europe&...
Find us at 7th Annual TPD & Induced Proximity Summit
October 28-31, The Westin Copley Place | Boston – MA (US). We are attending the 7th TPD & Induced Proximity Summit, in Boston.Meet our Head of Sales North America, Brian Jarecki, and team at...